Vancomycin vs. Vancomycin Plus Gentamycin in Treatment of MRSA Infection
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the outcome of treatment for bacteremic MRSA
infection with vancomycin alone, vancomycin plus gentamicin, vancomycin plus rifampin, and
vancomycin plus gentamicin and rifampin.
Phase:
Phase 4
Details
Lead Sponsor:
Michael E. DeBakey VA Medical Center VA Medical Center, Houston